SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
latest_posts
- 1
Doomed SpaceX Starlink satellite photographed from orbit - 2Old age isn’t a modern phenomenon – many people lived long enough to grow old in the olden days, too
- 3JFK's granddaughter reveals terminal cancer diagnosis, criticizes cousin RFK Jr.
- 4In Antarctica, photos show a remote area teeming with life amid growing risks from climate change
- 5EU delegation urges China to tighten export controls
- Ukrainian foreign minister appeals for funds for drones
- Understanding Preschool Projects: An Extensive Aide
- A definitive Manual for Picking Electric Vehicle: Decision in favor of Your Number one
- Internet Bookkeeping Programming for Consultants
- Lebanese Shi’a party Amal competing, coordinating with Hezbollah, experts tell ‘Post’
- UAE used military bases in Red Sea region to aid Israel's war against Hamas, leaks reveal
- Fundamental Home Machines: An Easy to understand Determination Guide
- Former GLP-1 users regain lost weight after about 18 months, study says
- MEPs urge Commission leaders to stop Russia from returning to the Venice Biennale
